Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis

Insa M. Schmidt,Mia R. Colona,Bryan R. Kestenbaum,Leonidas G. Alexopoulos,Ragnar Palsson,Anand Srivastava,Jing Liu,Isaac E. Stillman,Helmut G. Rennke,Vishal S. Vaidya,Haojia Wu,Benjamin D. Humphreys,Sushrut S. Waikar,Richard Knight,Stewart H. Lecker,Isaac Stillman,Steve Bogen,Afolarin A. Amodu,Titlayo Ilori,Shana Maikhor,Insa M. Schmidt,Laurence H. Beck,Joel M. Henderson,Ingrid Onul,Ashish Verma,Gearoid M. McMahon,M. Todd Valerius,Sushrut Waikar,Astrid Weins,Mia R. Colona,Anna Greka,Nir Hacohen,Paul J. Hoover,Jamie L. Marshall,Mark Aulisio,Yijiang M. Chen,Andrew Janowczyk,Catherine Jayapandian,Vidya S. Viswanathan,William S. Bush,Dana C. Crawford,Anant Madabhushi,Lakeshia Bush,Leslie Cooperman,Agustin Gonzalez-Vicente,Leal Herlitz,Stacey Jolly,Jane Nguyen,John O’toole,Ellen Palmer,Emilio Poggio,John Sedor,Dianna Sendrey,Kassandra Spates-Harden,Jonathan Taliercio,Petter M. Bjornstad,Laura Pyle,Carissa Vinovskis,Paul Appelbaum,Olivia Balderes,Jonathan M. Barasch,Andrew S. Bomback,Pietro A. Canetta,Vivette D. D’Agati,Krzysztof Kiryluk,Satoru Kudose,Karla Mehl,Ning Shang,Shweta Bansal,Theodore Alexandrov,Helmut Rennke,Tarek M. El-Achkar,Daria Barwinska,Sharon Bledso,Katy Borner,Andreas Bueckle,Yinghua Cheng,Pierre C. Dagher,Kenneth W. Dunn,Michael T. Eadon,Michael J. Ferkowicz,Bruce W. Herr,Katherine J. Kelly,Ricardo Melo Ferreira,Ellen M. Quardokus,Elizabeth Record,Marcelino Rivera,Jing Su,Timothy A. Sutton,James C. Williams,Seth Winfree,Yashvardhan Jain,Steven Menez,Chirag R. Parikh,Avi Rosenberg,Celia P. Corona-Villalobos,Yumeng Wen,Camille Johansen,Sylvia E. Rosas,Neil Roy,Jennifer Sun,Mark Williams,Evren U. Azeloglu,Jens Hansen,Cijang He,Ravi Iyengar,Yuguang Xiong,Pottumarthi Prasad,Anand Srivastava,Sethu M. Madhavan,Samir Parikh,Brad Rovin,John P. Shapiro,Christopher R. Anderton,Jessica Lukowski,Ljiljana Pasa-Tolic,Dusan Velickovic,George Oliver,Joseph Ardayfio,Jack Bebiak,Keith Brown,Taneisha Campbell,Catherine E. Campbell,Lynda Hayashi,Nichole Jefferson,Glenda V. Roberts,John Saul,Anna Shpigel,Christy Stutzke,Robert Koewler,Roy Pinkeney,Rachel Sealfon,Olga Troyanskaya,Aaron Wong,Katherine R. Tuttle,Ari Pollack,Yury Goltsev,Brandon Ginley,Nicholas Lucarelli,Brendon Lutnick,Pinaki Sarder,Blue B. Lake,Kun Zhang,Patrick Boada,Zoltan G. Laszik,Garry Nolan,Kavya Anjani,Minnie Sarwal,Tariq Mukatash,Tara Sigdel,Rita R. Alloway,Ashley R. Burg,Paul J. Lee,Adele Rike,Tiffany Shi,E. Steve Woodle,Heather Ascani,Ulysses G.J. Balis,Victoria M. Blanc,Ninive C. Conser,Sean Eddy,Renee Frey,Yougqun He,Jeffrey B. Hodgin,Matthias Kretzler,Chrysta Lienczewski,Jinghui Luo,Laura H. Mariani,Rajasree Menon,Edgar Otto,Jennifer Schaub,Becky Steck,Michele M. Elder,Matthew Gilliam,Daniel E. Hall,Raghavan Murugan,Paul M. Palevsky,Parmjeet Randhawa,Matthew Rosengart,Mitchell Tublin,Tina Vita,James Winters,John A. Kellum,Charles E. Alpers,Ashley Berglund,Brooke Berry,Kristina N. Blank,Jonas Carson,Stephen Daniel,Ian H. De Boer,Ashveena L. Dighe,Frederick Dowd,Stephanie M. Grewenow,Jonathan Himmelfarb,Andrew N. Hoofnagle,Christine Limonte,Robyn L. McClelland,Sean D. Mooney,Kasra Rezaei,Stuart Shankland,Jamie Snyder,Ruikang Wang,Adam Wilcox,Kayleen Williams,Christopher Park,Shweta Bansal,Richard Montellano,Annapurna Pamreddy,Kumar Sharma,Manjeri Venkatachalam,Hongping Ye,Guanshi Zhang,Mujeeb Basit,S. Susan Hedayati,Asra Kermani,Simon C. Lee,Christopher Y. Lu,R. Tyler Miller,Orson W. Moe,Jiten Patel,Anil Pillai,Kamalanathan Sambandam,Jose Torrealba,Robert D. Toto,Miguel Vazquez,Nancy Wang,Natasha Wen,Dianbo Zhang,Harold Park,Richard M. Caprioli,Nathan Patterson,Kavya Sharman,Jeffrey M. Spraggins,Raf Van de Plas,Jeanine Basta,Sabine M. Diettman,Joseph P. Gaut,Sanjay Jain,Michael I. Rauchman,Anitha Vijayan,Lloyd G. Cantley,Vijaykumar R. Kakade,Dennis Moledina,Melissa M. Shaw,Ugochukwu Ugwuowo,Francis P. Wilson,Tanima Arora,George (Holt) Oliver

DOI: https://doi.org/10.1016/j.kint.2021.04.037

IF: 19.6

2021-09-01

Kidney International

Abstract:<p>Kidney fibrosis constitutes the shared final pathway of nearly all chronic nephropathies, but biomarkers for the non-invasive assessment of kidney fibrosis are currently not available. To address this, we characterize five candidate biomarkers of kidney fibrosis: Cadherin-11 (CDH11), Sparc-related modular calcium binding protein-2 (SMOC2), Pigment epithelium-derived factor (PEDF), Matrix-gla protein, and Thrombospondin-2. Gene expression profiles in single-cell and single-nucleus RNA-sequencing (sc/snRNA-seq) datasets from rodent models of fibrosis and human chronic kidney disease (CKD) were explored, and Luminex-based assays for each biomarker were developed. Plasma and urine biomarker levels were measured using independent prospective cohorts of CKD: the Boston Kidney Biopsy Cohort, a cohort of individuals with biopsy-confirmed semiquantitative assessment of kidney fibrosis, and the Seattle Kidney Study, a cohort of patients with common forms of CKD. Ordinal logistic regression and Cox proportional hazards regression models were used to test associations of biomarkers with interstitial fibrosis and tubular atrophy and progression to end-stage kidney disease and death, respectively. Sc/snRNA-seq data confirmed cell-specific expression of biomarker genes in fibroblasts. After multivariable adjustment, higher levels of plasma CDH11, SMOC2, and PEDF and urinary CDH11 and PEDF were significantly associated with increasing severity of interstitial fibrosis and tubular atrophy in the Boston Kidney Biopsy Cohort. In both cohorts, higher levels of plasma and urinary SMOC2 and urinary CDH11 were independently associated with progression to end-stage kidney disease. Higher levels of urinary PEDF associated with end-stage kidney disease in the Seattle Kidney Study, with a similar signal in the Boston Kidney Biopsy Cohort, although the latter narrowly missed statistical significance. Thus, we identified CDH11, SMOC2, and PEDF as promising non-invasive biomarkers of kidney fibrosis.</p>

urology & nephrology